The report “Global Sickle Cell Disease Treatment Market, By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobin meters, Other Products), By Reagents (Coagulation Reagents, Flow Cytometer Reagents, Immuno-hematology Reagents, and Other Reagents), By Application (Drug Testing and Auto-Immune Disease), By End User (Hospitals, Clinical Testing Institutes, Patient Self-testing, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”


Key Highlights:
• In 2021, Bluebird bio, reeling from Zynteglo safety scare, snags EU nod for new gene therapy against rare neurodegenerative disease.
https://www.prophecymarketinsights.com/market_insight/Global-Sickle-Cell-Disease-Treatment-3832
Key Market Insights from the report:
The Global Sports Medicine Market accounted for US$ 1.50 billion in 2020 and is estimated to be US$ 5.12 billion by 2030 and is anticipated to register a CAGR of 13.1%. The global sickle cell disease treatment market is segmented based on the product, reagents, application, end-users, and region.
• By Product, the Global Sports Medicine Market is segmented into hematology analyzers, flow cytometers, coagulation analyzers, slide strainers, centrifuges, hemoglobin meters, other products.
• By Reagents, the Global Sports Medicine Market is segmented into coagulation reagents, flow cytometer reagents, immuno-hematology reagents, and other reagents.
• By Application, the Global Sports Medicine Market is segmented into drug testing and autoimmune disease.
• By End-User, the Global Sports Medicine Market is segmented into hospitals, clinical testing institutes, patient self-testing, and other end users.
• By region, the Global Sports Medicine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global sickle cell disease treatment market due to the increasing demand for advanced medical technologies and the rising geriatric population.
Competitive Landscape:
The key players operating the global sickle cell disease treatment market involves Baxter, Bluebird Bio, Bristol-Myers Squibb Company, Eli Lilly, Global Blood Therapeutics, Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc., Mast Therapeutics, Novartis AG, Pfizer, Inc., and Sanofi.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Contact Us:
Sales
Prophecy Market Insights
Email- [email protected]